CODX vs CTSH · rev $3.9M vs P/E 12, rev $19.74B
Co-Diagnostics, Inc. Common Stock (CODX) versus Cognizant Technology Solutions Corp Class A (CTSH) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported CTSH revenue for 2024-12-31 was $19.74B. Net income was $2.24B. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
CODX currently screens at market cap $31.4M. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Not investment advice. Open the CODX and CTSH stock pages for the full models.
Not investment advice.